Jakarta – In a strategic move signaling a shift in focus for Indonesia’s telecommunications giant, PT Telkom Indonesia (Persero) Tbk is divesting its entire stake in PT Administrasi Medika (AdMedika) and its subsidiary, TelkoMedika, to Fullerton Health, a leading integrated healthcare provider in Asia. The divestment, formalized through a Conditional Sale and Purchase Agreement (CSPA) on March 4, 2026, aligns with TelkomGroup’s broader restructuring efforts and a renewed commitment to its core telecommunications and digital businesses.
The decision to streamline its business portfolio comes as part of a mandate from the Indonesian government to optimize state-owned enterprises (BUMN), as outlined in the TLKM 30 transformation pillar. This restructuring aims to allow TelkomGroup to concentrate resources on its primary areas of expertise while simultaneously creating opportunities for AdMedika to expand its reach both domestically and regionally. The move reflects a growing trend within the Indonesian market towards specialization and strategic partnerships in the healthcare sector.
AdMedika has established itself as a prominent third-party administrator (TPA) in Indonesia, leveraging technology to manage healthcare administration services. Whereas, in an increasingly competitive landscape, TelkomGroup believes that AdMedika’s future growth will be best served under the guidance of a strategic partner with a direct focus on the healthcare industry. This allows AdMedika to benefit from Fullerton Health’s established regional network and specialized expertise.
TelkomGroup’s Strategic Shift and the Rationale for Divestment
Pramasaleh Haryo Utomo, Director Utama of TelkomMetra, emphasized that the divestment decision was made after careful consideration, prioritizing good corporate governance (GCG) and a comprehensive business assessment. “The signing of the CSPA with Fullerton Health is part of TelkomGroup’s transformation to strengthen its focus on core businesses and create long-term value for the company,” Utomo stated. TelkoMedika, a subsidiary of AdMedika, provides healthcare solutions through clinics, laboratories, pharmacies, and other healthcare facilities across major Indonesian cities including Jakarta, Medan, and Surabaya.
The Indonesian government has been actively encouraging state-owned enterprises to streamline their operations and focus on core competencies. This push for efficiency and specialization is intended to enhance the competitiveness of Indonesian businesses on a global scale. The divestment of AdMedika is a direct response to this directive, allowing TelkomGroup to allocate capital and resources to its core telecommunications and digital infrastructure projects. This strategic realignment is expected to drive innovation and growth within TelkomGroup’s primary business areas.
Fullerton Health’s Expansion in the Indonesian Healthcare Market
Fullerton Health, the acquiring entity, is a well-established healthcare provider with a significant presence across Asia. The company offers a comprehensive range of healthcare services, including primary care, specialist care, and dental services. Its acquisition of AdMedika represents a strategic expansion into the Indonesian market, one of the fastest-growing healthcare markets in Southeast Asia. TelkoMedika currently operates across seven regional offices in Indonesia, including Sumatera.
Ho Kuen Loon, Group CEO of Fullerton Health, expressed his enthusiasm for the acquisition, highlighting its alignment with the company’s commitment to enhancing healthcare access in Indonesia. “AdMedika has matured under TelkomGroup into a trusted health administration platform built on strong governance and digital innovation. This quality aligns with our values. We view this acquisition as an important step to expand access to high-quality healthcare services for the people of Indonesia and the region,” Loon said. Fullerton Health’s expertise in managed care and digital health solutions is expected to complement AdMedika’s existing capabilities, leading to improved service quality and expanded offerings.
Synergies and Future Prospects
The integration of AdMedika and Fullerton Health is anticipated to create significant synergies, leveraging the strengths of both organizations. AdMedika’s strong domestic presence and established network of healthcare providers will be combined with Fullerton Health’s regional expertise and advanced technological capabilities. This combination is expected to accelerate innovation in the Indonesian healthcare sector and enhance the overall patient experience.
Specifically, the partnership is expected to drive improvements in areas such as claims processing, data analytics, and preventative healthcare programs. Fullerton Health’s digital health solutions will be integrated into AdMedika’s platform, providing patients with greater access to online healthcare services and personalized health management tools. This focus on digital innovation is crucial in addressing the growing demand for convenient and accessible healthcare solutions in Indonesia.
the acquisition is expected to facilitate AdMedika’s regional expansion plans. Fullerton Health’s established network across Asia will provide a platform for AdMedika to extend its services to new markets and serve a wider customer base. This regional expansion will not only drive revenue growth but also contribute to the development of a more integrated and efficient healthcare ecosystem in Southeast Asia.
Impact on the Indonesian Healthcare Landscape
The divestment of AdMedika and its acquisition by Fullerton Health is likely to have a ripple effect throughout the Indonesian healthcare landscape. The increased competition and investment in the sector are expected to drive innovation and improve the quality of healthcare services available to Indonesian citizens. The focus on digital health solutions will also play a crucial role in addressing the challenges of access and affordability in the Indonesian healthcare system.
The move also reflects a broader trend towards consolidation in the healthcare industry, as companies seek to achieve economies of scale and enhance their competitive positions. Strategic partnerships and acquisitions are becoming increasingly common as healthcare providers strive to navigate the complexities of a rapidly evolving market. This consolidation is expected to lead to greater efficiency and improved coordination of care, ultimately benefiting patients and healthcare stakeholders alike.
Recent developments in Indonesia’s healthcare sector, including the implementation of the Universal Health Coverage (JKN) program, have created both opportunities and challenges for healthcare providers. The JKN program aims to provide affordable healthcare access to all Indonesian citizens, but it has also placed significant financial pressure on healthcare providers. The acquisition of AdMedika by Fullerton Health is expected to strengthen the company’s ability to navigate these challenges and continue to provide high-quality healthcare services to its customers.
AdMedika’s Recent Activities and Commitment to Clinical Governance
Prior to the acquisition, AdMedika demonstrated a commitment to strengthening its clinical governance. In March 2026, AdMedika reinforced its clinical governance based on data analytics through the strengthening of its Medical Advisory Board (MAB), responding to new regulations from the Financial Services Authority (POJK No. 36 of 2025) regarding medical capability, digital oversight, and independent medical advisory boards. PT. Administrasi Medika (AdMedika), as a Third Party Administrator (TPA) and subsidiary of Telkom Indonesia, leverages its technological capabilities and integrated claims management experience.
AdMedika has been actively involved in supporting various community health initiatives. In early March 2026, the company provided medical support for the Telkom Metra sports agenda in Yogyakarta and conducted comprehensive medical check-ups for employees of Sari Roti Gresik, demonstrating its commitment to promoting employee health and well-being.
These initiatives underscore AdMedika’s dedication to providing comprehensive healthcare solutions and its commitment to improving the health of the Indonesian population. The acquisition by Fullerton Health is expected to build upon these efforts and further enhance AdMedika’s ability to deliver high-quality healthcare services.
Key Takeaways:
- TelkomGroup is divesting AdMedika and TelkoMedika to Fullerton Health as part of a strategic restructuring.
- The move allows TelkomGroup to focus on its core telecommunications and digital businesses.
- Fullerton Health aims to expand its presence in the Indonesian healthcare market through this acquisition.
- The integration of AdMedika and Fullerton Health is expected to drive innovation and improve healthcare access.
The completion of the transaction is subject to regulatory approvals. Further updates regarding the integration process and future plans will be announced by Fullerton Health and TelkomGroup in due course. Stakeholders are encouraged to monitor official announcements for the latest information. The Indonesian healthcare sector will be closely watching the developments as this acquisition unfolds and reshapes the competitive landscape.
Do you have thoughts on this strategic shift in the Indonesian healthcare market? Share your comments below and join the conversation.